Survivors of head and neck cancers are at risk for delayed neurocognitive deficits for at least two years following radiotherapy or chemotherapy
Should More Conservative Blood Transfusion Thresholds Be Adopted in Head and Neck Surgery?
Questions remain regarding the ideal criteria for transfusion in these patients.
Should Surgeons Routinely Inform Patients about Risks of Taste Dysfunction after Tongue Base Surgery for Sleep Apnea?
The incidence of alteration in taste sensation with coblation lingual tonsillectomy, TORS tongue-base reduction, and submucosal lingualplasty is sufficiently high to warrant warning patients.
Can Topical Beta-Blockers Reduce the Size of Superficial Infantile Hemangiomas of the Head and Neck?
Topical beta-blocker therapy is a safe treatment for patients that meet a certain criteria
What Is the Evidence for Open Versus Closed Treatment of Mandibular Condylar Fractures In Adults?
The decision is one of the greatest debates within maxillofacial trauma
Drug Shrinks Multiple Cancer Tumor Types with Same Genetic Defect
Targeted therapy shows promise in clinical trials for both pediatric and adult patients
Complications from Surgery for Thyroid Cancer More Common than Previously Thought
Overall 12% of patients experienced complications specific to the surgery within a year following the procedure.
Modern Endovascular Approaches Yield Positive Results for Acute CBS Management
Olfactory Impairment and Disease Etiology areLinked
Sex-Specific Therapies for Treating Head, Neck, and Thyroid Cancers
In addition to the known sex-specific cancer types, such as ovarian and prostate cancers, there are significant gender disparities in non-sex-specific cancers, such as rate of incidence and susceptibility, tumor […]
The Role of Checkpoint Inhibitors in the Treatment of Head and Neck Cancer
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 42
- Next Page »